Table: Oncolys Biopharma -2018 parent forecast
Jan 18 (Reuters) -
Oncolys Biopharma Inc.
PARENT- ONLY EARNINGS ESTIMATES
(in billions of yen unless specified)
Full Year to Full Year to
Dec 31, 2018 Dec 31, 2018
LATEST PREVIOUS
FORECAST FORECAST
Sales 160 mln 230 mln
Operating loss 1.25 loss 1.40
Recurring loss 1.25 loss 1.40
Net loss 1.25 loss 1.40
EPS loss 93.66 yen loss 126.29 yen
NOTE - Oncolys Biopharma Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T